Search Results (1 to 10 of 268 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 84 Journal of Medical Internet Research
- 37 JMIR Research Protocols
- 31 JMIR Public Health and Surveillance
- 30 JMIR Formative Research
- 28 JMIR mHealth and uHealth
- 16 Online Journal of Public Health Informatics
- 7 JMIR Medical Informatics
- 5 JMIR Human Factors
- 5 JMIR Serious Games
- 4 JMIR Cancer
- 4 JMIR Mental Health
- 3 Interactive Journal of Medical Research
- 2 JMIR AI
- 2 JMIR Dermatology
- 2 JMIR Infodemiology
- 2 JMIR Medical Education
- 2 JMIR Pediatrics and Parenting
- 2 JMIR Rehabilitation and Assistive Technologies
- 1 JMIR Nursing
- 1 JMIR Perioperative Medicine
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Aging
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
By collecting 100,000 gut microbiota profiles combined with metadata on diet, health, and lifestyle, “Le French Gut – Le Microbiote Français” aims at (1) better understanding the heterogeneity of healthy gut microbiota and its link with nutrition, lifestyle, and anthropometric characteristics and (2) predicting changes in gut microbiota associated with diseases such as chronic diseases, neurodevelopmental disorders, and neurodegenerative conditions.
JMIR Res Protoc 2025;14:e64894
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
A total of 53 patients were included between July 12, 2017, and April 7, 2020, from 14 centers in France: Le Mans (16/52, 31%), Besançon (9/52, 17%), Nantes (6/52, 11%), Bordeaux Bergonié (6/52,11%), Bordeaux Nord (6/52, 11%), Mont de Marson (4/52, 8%), Dijon (1/52, 2%), Grenoble (1/52, 2%), Paris (1/52, 2%), Strasbourg (1/52, 2%), and Vannes (1/52, 2%). One patient withdrew consent before randomization, and 27 patients were randomized to the experimental arm and 25 to the control arm.
JMIR Cancer 2025;11:e65960
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section